From April 19 through 21, 2010 biotechnological company “Alkor Bio” producing reagents for laboratory diagnostics participate in international exhibition and conference “Medical Laboratory”, Kiev. Conference is going be devoted to the development tends of Ukraine laboratory diagnostics and to the laboratory tests standardization and quality control.

Maria Bessonova, vice director of “Alkor Bio” Marketing Department presents to the conference audience report “Contemporary conception of biochemical prenatal screening. Prenatal risk assessment software “Isida”. It ought to note that in Saint-Petersburg prenatal diagnostics has come to a quantitative new level. If a few years ago there were 63-65 children born with Down syndrome annually, however, in 2009 already 48 cases birth of child with diagnosed Down syndrome were prevented. Such significant changes became real due to the wide range of measures. One of them was prenatal screening which was a must to every pregnant woman by decision of Healthcare Government of Saint-Petersburg. Each pregnant woman had to pass throw ultrasound and biochemical testing.

Contemporary trends of biochemical prenatal screening during the Ist and IInd trimester and importance of such tests are the main topics of report with would be present by Saint-Petersburg company representative. Among other products “Alkor Bio” develops and produces reagent kits for biochemical prenatal testing. “Alkor Bio” products have been on the Ukraine laboratory market for more than 9 years. All these kits used in medical practice have registration in Ukraine Healthcare Ministry.

The exhibition and conference “Medical Laboratory” is held under the patronage of the Healthcare Committee of Verkhovna Rada of Ukraine, Ukraine Healthcare Ministry, National Science Academy and Ukraine Associations of Clinical Chemistry and Laboratory Medicine.